ACI Summit on Controlled Substances – Regulation, Litigation, and Enforcement

Jodi Avergun will discuss “Reassessing your Responsibilities in Light of the Changing Scope of Suspicious Order Monitoring Requirements” at the ACI’s Summit on Controlled Substances- Regulation, Litigation, and Enforcement in Washington, D.C., on January 30, 2018.

Opioid abuse and related deaths have touched every state, city and county, and the related statistics are shocking. As a result, federal and state authorities are going after controlled substance manufacturers, distributors, pharmacies, pharmacists, physicians, nurses — anyone and everyone who has a hand in the chain of custody for these products.

This is a one-of-a-kind, interactive forum where stakeholders from every step in the supply chain can discuss their current challenges and benchmark strategies, and join together to best prepare for the future of this critical and fast-paced industry.

CadwaladerNews

CadwaladerSpotlight

June 27: SFIG Legal Counsel Forum 2018

Partners Scott Cammarn and Neil Weidner will be speaking at this event in New York City.

Cadwalader's research and intelligence platform provides analysis on changes in U.S. financial regulation. Subscribers receive a daily newsletter interpreting new laws, rules and enforcement actions that impact financial institutions.